Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune polyglandular syndromes.

W J Riley1

  • 1Department of Pathology and Laboratory Medicine, University of Florida College of Medicine, J Hillis Miller Health Center, Gainesville.

Hormone Research
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Greening of the land surface in the world's cold regions consistent with recent warming.

Nature climate change·2018
Same author

Fine-root mortality rates in a temperate forest: estimates using radiocarbon data and numerical modeling.

The New phytologist·2009
Same author

Fine-root turnover patterns and their relationship to root diameter and soil depth in a 14C-labeled hardwood forest.

The New phytologist·2006
Same author

Estimating contaminant dose for intermittent dermal contact: model development, testing, and application.

Risk analysis : an official publication of the Society for Risk Analysis·2004
Same author

Ingested IFN-alpha preserves residual beta cell function in type 1 diabetes.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2002
Same author

Dynamic behavior of semivolatile organic compounds in indoor air. 2. Nicotine and phenanthrene with carpet and wallboard.

Environmental science & technology·2001
Same journal

Abstracts of the LWPES/ESPE 8th Joint Meeting Global Care in Paediatric Endocrinology, in collaboration with APEG, APPES, JSPE and SLEP. New York City, New York, USA. September 9-12, 2009.

Hormone research·2011
Same journal

Abstracts of the 47th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Istanbul, Turkey. September 20-23, 2008.

Hormone research·2011
Same journal

Abstracts of the 46th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Helsinki, Finland. June 27-30, 2007.

Hormone research·2011
Same journal

Genetic and pathogenetic aspects of Noonan syndrome and related disorders.

Hormone research·2009
Same journal

Response to growth hormone in short children with Noonan syndrome: correlation to genotype.

Hormone research·2009
Same journal

Growth hormone and the heart in Noonan syndrome.

Hormone research·2009
See all related articles

Autoimmune polyglandular syndromes (APS) are classified into three types. Autoantibodies aid in diagnosing APS and identifying at-risk individuals for related diseases.

Area of Science:

  • Endocrinology
  • Immunology
  • Genetics

Background:

  • Autoimmune polyglandular syndromes (APS) are a group of rare disorders characterized by autoimmune activity against multiple endocrine glands.
  • Originally classified into three types (I, II, and III), APS involves a complex interplay of genetic predisposition and immune dysregulation.
  • The autoimmune basis is supported by lymphocytic infiltration, organ-specific autoantibodies, and associations with HLA genes.

Purpose of the Study:

  • To review the clinical and serological spectrum of Autoimmune Polyglandular Syndromes Type I and Type II.
  • To highlight the diagnostic utility of autoantibodies in identifying APS and predicting disease progression.
  • To discuss the genetic associations and immune mechanisms underlying APS.

Main Methods:

Related Experiment Videos

  • Literature review of clinical and serological data for Autoimmune Polyglandular Syndromes Types I and II.
  • Analysis of diagnostic criteria, including autoantibody profiles and genetic markers.
  • Synthesis of information on the pathogenesis and clinical manifestations.

Main Results:

  • Type I and Type II Autoimmune Polyglandular Syndromes are distinct clinical entities, while Type III remains less defined.
  • Organ-specific autoantibodies are crucial diagnostic markers and can predict the development of other component diseases.
  • Association with HLA DR/DQ genes and immune response genes is a key feature.

Conclusions:

  • Autoimmune Polyglandular Syndromes Types I and II have well-defined clinical and serological characteristics.
  • Autoantibody detection is vital for early diagnosis and risk stratification in APS patients.
  • Further research into the genetic and immunological underpinnings of APS is warranted.